0001193125-22-092360 Sample Contracts

Forte Biosciences, Inc. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement
Forte Biosciences, Inc. • April 1st, 2022 • Pharmaceutical preparations • New York

Forte Biosciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Agent”) as follows:

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.